Timothy J Toner
Overview
Explore the profile of Timothy J Toner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
359
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Aste-Amezaga M, Zhang N, Lineberger J, Arnold B, Toner T, Gu M, et al.
PLoS One
. 2010 Feb;
5(2):e9094.
PMID: 20161710
Background: Notch receptors normally play a key role in guiding a variety of cell fate decisions during development and differentiation of metazoan organisms. On the other hand, dysregulation of Notch1...
2.
Youil R, Toner T, Su Q, Casimiro D, Shiver J, Chen L, et al.
Hum Gene Ther
. 2003 Jul;
14(10):1017-34.
PMID: 12869219
First-generation adenovectors have been developed for gene therapy and vaccine applications. The construction of these adenovectors has entailed the use of numerous types of expression cassettes. It has long been...
3.
Casimiro D, Chen L, Fu T, Evans R, Caulfield M, Davies M, et al.
J Virol
. 2003 May;
77(11):6305-13.
PMID: 12743287
Cellular immune responses, particularly those associated with CD3(+) CD8(+) cytotoxic T lymphocytes (CTL), play a primary role in controlling viral infection, including persistent infection with human immunodeficiency virus type 1...
4.
Szymkowiak C, Kwan W, Su Q, Toner T, Shaw A, Youil R
J Virol Methods
. 2002 Nov;
107(1):15-20.
PMID: 12445933
A T4 RNA ligase based strategy is demonstrated that allows for the full characterization of 3' and 5' UTR regions of negative strand RNA viruses. Negative strand RNA viruses such...
5.
Youil R, Toner T, Su Q, Chen M, Tang A, Bett A, et al.
Hum Gene Ther
. 2002 Jan;
13(2):311-20.
PMID: 11812286
The usefulness of adenovirus as a vehicle for transgene delivery is limited greatly by the induction of neutralizing anti-adenoviral immunity following the initial administration, thereby resulting in shorter-term and reduced...